New York, NY -- (SBWIRE) -- 01/28/2014 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: GTx, Inc. (NASDAQ:GTXI), WPCS International Incorporated (NASDAQ:WPCS), Idera Pharmaceuticals Inc (NASDAQ:IDRA), DARA Biosciences Inc (NASDAQ:DARA)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
GTx, Inc. (NASDAQ:GTXI) opened its shares at the price of $1.87 for the day. Its closing price was $1.72 after losing -8.51% for the day. The company traded with the total volume of 1.10 million shares, while its average trading volume remained 969,355.00 shares. The beta of GTXI stands at1.39. GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions.
Has GTXI Found The Bottom and Ready To Move Up? Find Out Here
WPCS International Incorporated (NASDAQ:WPCS) percentage change plunged -8.43% to close at $1.52 with the total traded volume of 1.01 million shares, and average volume of 3.31 million. The 52 week range of the stock remained $1.32- $5.27, while its day lowest price was $1.52 and it hit its day highest price at $1.70. WPCS International Incorporated provides design-build engineering services for communications infrastructure worldwide. Its Wireless Communication segment designs and deploys wireless network solutions comprising Wi-Fi networks.
Has WPCS Found The Bottom And Ready To Gain Momentum? Find Out Here
Idera Pharmaceuticals Inc (NASDAQ:IDRA) started its trading session with the price of $4.03 and closed at $3.71by scoring -7.71%. IDRA’s stocks traded with total volume of 2.16 million shares, while the average trading volume remained 2.83 million shares. The beta of IDRA stands at 2.03. Day range of the stock was $3.56 -$4.13. Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, engages in the discovery and development of novel synthetic DNA- and RNA- based drug candidates. It is developing drug candidates designed to modulate immune responses mediated through Toll-like Receptors (TLRs).
Why Should Investors Buy IDRA After the Recent Fall? Just Go Here and Find Out
DARA Biosciences Inc (NASDAQ:DARA) ended its day with the loss of -7.27% and closed at the price of $0.740 after opening at $0.78. Stock traded during its last trading session with the total volume of 2.08 million shares, as compared to its average volume of 1.87 million shares. DARA BioSciences, Inc., a development stage biopharmaceutical company, develops and commercializes oncology treatment and supportive care pharmaceutical products in the United States. It offers Soltamox for the chronic treatment of breast cancer or for cancer prevention in certain susceptible breast cancer subgroups.
Will DARA Get Buyers Even After The Recent Rally? Find Out Here
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)